[{"notes_id":"1_1214","category":"8","subcategory":"0","title":"Tumour markers","body":"Tumour markers may be divided into:<br \/><ul><li>monoclonal antibodies against carbohydrate or glycoprotein tumour antigens<\/li><li>tumour antigens<\/li><li>enzymes (alkaline phosphatase, neurone specific enolase)<\/li><li>hormones (e.g. calcitonin, ADH)<\/li><\/ul><br \/>It should be noted that tumour markers usually have a low specificity<br \/><br \/><h5 class='notes-heading'>Monoclonal antibodies<\/h5><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Tumour marker<\/b><\/th><th><b>Association<\/b><\/th><\/tr><\/thead><tbody><tr><td>CA 125<\/td><td><span class=\"concept\" data-cid=\"7679\">Ovarian cancer<\/span><\/td><\/tr><tr><td>CA 19-9<\/td><td><span class=\"concept\" data-cid=\"7680\">Pancreatic cancer<\/span><\/td><\/tr><tr><td>CA 15-3<\/td><td><span class=\"concept\" data-cid=\"4848\">Breast cancer<\/span><\/td><\/tr><\/tbody><\/table><\/div><br \/><h5 class='notes-heading'>Tumour antigens<\/h5><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th><b>Tumour marker<\/b><\/th><th><b>Association<\/b><\/th><\/tr><\/thead><tbody><tr><td>Prostate specific antigen (PSA)<\/td><td>Prostatic carcinoma<\/td><\/tr><tr><td>Alpha-feto protein (AFP)<\/td><td><span class=\"concept\" data-cid=\"7681\">Hepatocellular carcinoma<\/span>, <span class=\"concept\" data-cid=\"7682\">teratoma<\/span><\/td><\/tr><tr><td>Carcinoembryonic antigen (CEA)<\/td><td><span class=\"concept\" data-cid=\"1487\">Colorectal cancer<\/span><\/td><\/tr><tr><td>S-100<\/td><td><span class=\"concept\" data-cid=\"7683\">Melanoma<\/span>, <span class=\"concept\" data-cid=\"7684\">schwannoma<\/span>s<\/td><\/tr><tr><td>Bombesin<\/td><td><span class=\"concept\" data-cid=\"4847\">Small cell lung carcinoma<\/span>, gastric cancer, <span class=\"concept\" data-cid=\"7685\">neuroblastoma<\/span><\/td><\/tr><\/tbody><\/table><\/div>","notes_hash":"d890e7160baff9038e40eaa6766d412e","knowledge_graph_node_id_link":10569,"links":"<table style='width:100%'><tr><td>National Cancer Institute<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_96\" data-linkid=\"96\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_96\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">35<\/span><button type=\"button\" style=\"\" id=\"link_dislike_96\" data-linkid=\"96\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_96\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">19<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.cancer.gov\/about-cancer\/diagnosis-staging\/diagnosis\/tumor-markers-fact-sheet\">Tumour markers<\/a><\/td><\/tr><\/table>","media":"","concepts_for_notes":{"1487":{"concept_text":"Carcinoembryonic Antigen (CEA) is a tumour marker in colorectal cancer and has a role in monitoring disease activity","concept_percentile":"38"},"4848":{"concept_text":"CA 15-3 is a tumour marker in breast cancers","concept_percentile":"27"},"7679":{"concept_text":"Ovarian cancer - CA 125","concept_percentile":"17"},"7680":{"concept_text":"Pancreatic cancer - CA 19-9","concept_percentile":"33"},"7681":{"concept_text":"Hepatocellular carcinoma - alpha-feto protein","concept_percentile":"50"},"7682":{"concept_text":"Teratoma - alpha-feto protein","concept_percentile":"35"}},"category_name":"Pharmacology and therapeutics","subcategory_name":"","comment_count":2},"",[]]